ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 31 filers reported holding ASCENDIS PHARMA A/S in Q4 2016. The put-call ratio across all filers is - and the average weighting 1.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,822,000 | +0.7% | 90,000 | 0.0% | 1.96% | +10.1% |
| Q3 2016 | $1,809,000 | +51.5% | 90,000 | 0.0% | 1.78% | +43.8% |
| Q2 2016 | $1,194,000 | -28.5% | 90,000 | 0.0% | 1.24% | -14.7% |
| Q1 2016 | $1,670,000 | +1.3% | 90,000 | 0.0% | 1.45% | +45.4% |
| Q4 2015 | $1,649,000 | -88.5% | 90,000 | -88.9% | 1.00% | -72.9% |
| Q3 2015 | $14,357,000 | +2.0% | 811,152 | 0.0% | 3.68% | -7.3% |
| Q2 2015 | $14,070,000 | +9.0% | 811,152 | 0.0% | 3.97% | +33.5% |
| Q1 2015 | $12,911,000 | – | 811,152 | – | 2.97% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 2,003,147 | $225,574,000 | 20.44% |
| RA Capital Management | 4,914,955 | $553,473,000 | 17.48% |
| Sofinnova Investments, Inc. | 1,109,874 | $124,983,000 | 11.56% |
| Eversept Partners, LP | 275,494 | $31,023,379 | 7.71% |
| Avoro Capital Advisors LLC | 1,787,000 | $201,234,000 | 6.79% |
| Orbimed Advisors | 3,287,400 | $370,194,000 | 6.22% |
| Eventide Asset Management | 1,698,648 | $191,285,000 | 6.19% |
| Logos Global Management LP | 120,000 | $13,513,000 | 5.14% |
| Ghost Tree Capital, LLC | 150,000 | $16,892,000 | 4.48% |
| Spyglass Capital Management LLC | 351,388 | $39,570,000 | 4.47% |